PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
September 17, 2026Comprehensive physiology

Neuro‐Immune Interaction: A New Therapeutic Target for Cardiovascular Diseases

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Key result

Cardiovascular disease is increasingly recognized as a consequence of maladaptive neuroimmune interactions, supporting the development of precision therapies targeting the neuroimmune axis.

Authors

XMXuefang MaKYKe YangAFAodi Fan

Discussion

Loading...

Member takes

Overview

Neuroimmune axis may guide future trial design; leaves open whether targeted therapies will alter cardiovascular outcomes.

Key Points

  • Synthesize recent advances in cardiac neuroimmunology and evaluate how reciprocal cross-talk among the nervous, immune, and cardiovascular systems drives cardiovascular pathology.
  • Reviewed mechanistic evidence on autonomic innervation, immune cell dynamics, neural reflex circuits, and neurotransmitter–cytokine signaling in cardiac homeostasis.
  • Evaluated disease-specific neuroimmune pathways in atherosclerosis, myocardial infarction, heart failure, myocarditis, and arrhythmias alongside emerging neuromodulatory therapies.
  • Disrupted feedback between autonomic nerves and immune pathways drives persistent inflammation, structural remodeling, and cardiac electrical instability across disease stages.
  • Immune cells actively modulate neural signaling and myocardial electrophysiology, demonstrating functional bidirectional integration in cardiovascular pathogenesis.

PICO

P
Population
Cardiovascular disease
I
Intervention / Comparator
Neuromodulatory strategies targeting the neuroimmune axis

This review highlights the critical role of neuroimmune interactions in cardiovascular disease pathogenesis and proposes the neuroimmune axis as a novel therapeutic target.

Cite This Study

Ma et al. (2026) conducted a review in Cardiovascular disease. Neuromodulatory strategies targeting the neuroimmune axis was evaluated. Cardiovascular disease is increasingly recognized as a consequence of maladaptive neuroimmune interactions, supporting the development of precision therapies targeting the neuroimmune axis.

synapsesocial.com/papers/6aabb6725f706d05830e4ee0https://doi.org/10.1002/cph4.70256
View Full Paper
Ask AI
Bookmark
Share